Maraviroc, an inhibitor of chemokine receptor type 5, alleviates neuroinflammatory response after cerebral Ischemia/reperfusion injury via regulating MAPK/NF-κB signaling
Author:
Publisher
Elsevier BV
Subject
Pharmacology,Immunology,Immunology and Allergy
Reference21 articles.
1. Diagnosis and management of acute ischaemic stroke;Hurford;Practical neurology,2020
2. Efficacy of the CCR5 antagonist maraviroc in reducing early, ritonavir-induced atherogenesis and advanced plaque progression in mice;Cipriani;Circulation,2013
3. Update on Treatment of Acute Ischemic Stroke;Rabinstein;Continuum (Minneap Minn),2020
4. Emerging neuroprotective drugs for the treatment of acute ischaemic stroke;Schmidt;Expert Opin. Emerging Drugs,2013
5. HIV-1 neuroimmunity in the era of antiretroviral therapy;Kraft-Terry;Neurobiol. Dis.,2010
Cited by 21 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Decreased Astrocytic CCL5 by MiR-324-5p Ameliorates Ischemic Stroke Injury via CCR5/ERK/CREB Pathway;2024-09-03
2. CCR5 antagonist maraviroc alleviates doxorubicin-induced neuroinflammation and neurobehavioral deficiency by regulating NF-κB/NLRP3 signaling in a breast cancer mouse model;Neuropharmacology;2024-08
3. The chemokine receptor type 5 inhibitor maraviroc alleviates sepsis- associated liver injury by regulating MAPK/NF-κB signaling;2024-04-05
4. CCR5 and inflammatory storm;Ageing Research Reviews;2024-04
5. CC Chemokine Family Members’ Modulation as a Novel Approach for Treating Central Nervous System and Peripheral Nervous System Injury—A Review of Clinical and Experimental Findings;International Journal of Molecular Sciences;2024-03-28
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3